Insider screener

Period: 12 months + Add filter
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60,084 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60,084 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60,084 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60,084 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60,084 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60,084 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60,084 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Nassy Michael G. Sr EVP, Chief Credit Officer
Sold at will
$48.24K 3,100 at 15.56
5.3%
Not planned
2 Mar 2026
Poulton Stuart EVP, Chief Development Officer
Sold at will
$48.00K 5,101 at 9.41
5.1%
Not planned
2 Mar 2026
Mezvinsky Scott KFC Division CEO
Sold on a plan
$47.73K 287 at 166.29
100%
Sold half or more
2 Mar 2026
Rangwala Reshma EVP & Chief Medical Officer
Sold at will
$47.67K 5,066 at 9.41
8.2%
Not planned
2 Mar 2026
Dayton Judd Director
Bought
$47.57K 10,500 at 4.53
15.0%
2 Mar 2026
McGillis Mike PRESIDENT AND CFO
Bought
$46.79K 20,000 at 2.34
3.4%
2 Mar 2026
O'Dea Regan Patrick VP, General Counsel
Bought
$45.10K 578 at 78.04
3.9%
First buy on file
2 Mar 2026
PASQUALE DOUGLAS M Director · indirect
Bought 2×
$45.06K 1,500 at 30.04
7.5%
First buy on file
2 Mar 2026
Glaser Rachel C Director
Bought
$44.94K 1,000 at 44.94
31.7%
First buy on file
2 Mar 2026
Weinberg Uri Chf Medical and Innovation Ofr
Sold at will
$43.61K 3,272 at 13.33
1.4%
Not planned
2 Mar 2026
Sold on a plan
$43.37K 1,000 at 43.37
0.7%
Planned (10b5-1)
2 Mar 2026
Cheng Sohanya Roshan EVP & Chief Commercial Officer
Sold at will
$43.32K 4,604 at 9.41
4.1%
Not planned
2 Mar 2026
Saint Sean President & CEO
Sold at will
$41.83K 3,384 at 12.36
0.8%
Not planned
2 Mar 2026
Bought
$41.24K 1,665 at 24.77
4.3%
First buy on file
2 Mar 2026
Carson Seana EVP, General Counsel
Sold on a plan
$39.63K 6,856 at 5.78
0.9%
Planned (10b5-1)
2 Mar 2026
Turner Christopher Lee CEO, Chairman of Board
Sold on a plan
$39.58K 238 at 166.29
0.4%
Planned (10b5-1)
2 Mar 2026
TEAL-GUESS KELLIE Chief Human Resources Officer
Sold on a plan
$38.49K 21,266 at 1.81
2.0%
Planned (10b5-1)
2 Mar 2026
Skinner Todd C. President, International
Sold on a plan
$38.32K 500 at 76.64
0.9%
Planned (10b5-1)
2 Mar 2026
Swartz Allison EVP, GC
Sold on a plan
$37.98K 2,199 at 17.27
2.2%
Planned (10b5-1)
2 Mar 2026
Caldwell Jonathan L. Chief People Officer
Sold on a plan
$37.35K 983 at 38.00
3.6%
Planned (10b5-1)
2 Mar 2026
Taylor Peter J. Director
Sold on a plan
$37.27K 500 at 74.54
1.4%
Planned (10b5-1)
2 Mar 2026
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold at will
$37.21K 1,632 at 22.80
3.2%
Not planned
2 Mar 2026
Marino Mark A. Chief Financial Officer
Sold on a plan
$36.53K 20,183 at 1.81
0.9%
Planned (10b5-1)
2 Mar 2026
Kaseta Michael CFO and COO
Sold on a plan
$35.63K 1,165 at 30.58
0.3%
Planned (10b5-1)
2 Mar 2026
Schubach Sarah Elizabeth Chief Accounting Officer
Sold on a plan
$35.04K 1,415 at 24.76
1.6%
Planned (10b5-1)
2 Mar 2026
Kavanaugh Ashley VP, Principal Accting Officer · indirect
Sold at will
$35.01K 836 at 41.88
48.5%
Not planned
2 Mar 2026
ARNOLD FRANCES Director
Sold on a plan
$33.93K 112 at 302.99
0.6%
Planned (10b5-1)
2 Mar 2026
Sold at will
$33.84K 1,802 at 18.78
2.6%
Not planned
2 Mar 2026
Mano Michael EVP, CLO&Secretary
Sold at will
$33.18K 3,526 at 9.41
3.6%
Not planned
2 Mar 2026
Rouse Paul D CFO, Executive VP & Treasurer
Bought
$32.90K 14,000 at 2.35
4.2%
First buy on file
2 Mar 2026
Schundler Russell General Counsel
Sold on a plan
$32.81K 1,073 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$32.00K 5,894 at 5.43
3.2%
Not planned
2 Mar 2026
Silvers Jason President & CFO · indirect
Bought 3×
$32.00K 2,000 at 16.00
opened
First buy on file
2 Mar 2026
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$31.60K 5,820 at 5.43
4.5%
Not planned
2 Mar 2026
John Robert Allen Chief Revenue Officer
Sold on a plan
$31.33K 3,964 at 7.90
4.4%
Planned (10b5-1)
2 Mar 2026
Mutz Christopher HEAD OF RARE DISEASE
Sold on a plan
$30.86K 417 at 74.00
0.4%
Planned (10b5-1)
2 Mar 2026
Cushman Elizabeth C. EVP, GC AND SECRETARY
Sold at will
$30.40K 263 at 115.58
0.7%
Not planned
2 Mar 2026
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$30.17K 5,566 at 5.42
3.5%
Not planned
2 Mar 2026
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$30.16K 5,565 at 5.42
3.2%
Not planned
2 Mar 2026
BENHAM DOUGLAS N Director · indirect
Bought
$29.04K 1,200 at 24.20
2.8%
2 Mar 2026
Davis Jason Chief Financial Officer
Bought
$28.97K 70,000 at 0.41
opened
First buy on file
2 Mar 2026
Thomas John Director
Sold on a plan
$28.96K 10,000 at 2.90
2.0%
Planned (10b5-1)
2 Mar 2026
Szczepaniak Mark R Chief Financial Officer · indirect
Sold on a plan
$28.82K 1,573 at 18.32
2.1%
Planned (10b5-1)
2 Mar 2026
Bought
$28.67K 1,300 at 22.05
42.2%
Largest buy in 3 yrs
2 Mar 2026
Amato Gerald Director
Sold at will
$28.30K 2,000 at 14.15
3.1%
Not planned
2 Mar 2026
Olsen Michael General Counsel and CCRO
Sold on a plan
$28.00K 20,000 at 1.40
1.6%
Planned (10b5-1)
2 Mar 2026
Finn Mark Steven Director
Bought
$27.72K 1,000 at 27.72
6.3%
2 Mar 2026
Vieira Cory Chief Accounting Officer
Sold at will
$27.19K 2,490 at 10.92
14.1%
Not planned
2 Mar 2026
Barrett David Michael Chief Executive Officer · indirect
Sold on a plan
$27.00K 30,000 at 0.90
2.3%
Planned (10b5-1)
2 Mar 2026
Akinsanya Karen See Remarks
Sold on a plan
$26.45K 2,206 at 11.99
3.0%
Planned (10b5-1)
Showing 39,401–39,450 of 60,084. ← Newer Page 789 of 1,202 Older →